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MicroRNA (miRNA)-dependent regulation of gene
expression confers robustness to cellular pheno-
types and controls responses to extracellular stimuli.
Although a single miRNA can regulate expression of
hundreds of target genes, it is unclear whether any of
its distinct biological functions can be due to the
regulation of a single target. To explore in vivo the
function of a single miRNA-mRNA interaction, we
mutated the 30 UTR of a major miR-155 target
(SOCS1) to specifically disrupt its regulation by
miR-155. We found that under physiologic condi-
tions and during autoimmune inflammation or viral
infection, some immunological functions of miR-
155 were fully or largely attributable to the regulation
of SOCS1, whereas others could be accounted only
partially or not at all by this interaction. Our data sug-
gest that the role of a single miRNA-mRNA interac-
tion is dependent on cell type and biological context.
INTRODUCTION
The microRNA (miRNA)-mediated posttranscriptional regulation
of gene expression features prominently during differentiation of
cells of the immune system and their responses to stimulation as
revealed by miRNA gene targeting in mice (Baltimore et al.,
2008). The ability of a given miRNA to bind and control its targets
is determined by perfect complementarity of the ‘‘seed’’ region
at positions 2–7 in the 50 end of the miRNA to the 30 UTR of the
target mRNA followed by Argonaute (Ago) protein-containing
RNA-induced silencing complex (RISC)-mediated target inhibi-
tion (Bartel, 2004). This attribute enabled computational predic-
tion of thousands of miRNA targets based on changes in tran-
script and protein levels induced upon genetic perturbation of52 Immunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc.miRNAs and their confirmation via in vitro reporter assays (Bar-
tel, 2009). A single miRNA binds and inhibits expression of hun-
dreds of targets overwhelmingly on a small scale of 2-fold or less.
The characteristically small range variation of multiple targets
imparted by a given miRNA and their frequent enrichment in
the same or related molecular pathways strongly suggest that
regulation of a single target is unlikely to account for a particular
biological manifestation of the individual miRNA activity with
exception of targets with a highly pronounced gene dose effect
(Xiao et al., 2007). However, the vast majority of functional
studies of miRNAs in mice ascribed their specific biological
effects to changes in expression of a single target. The ‘‘gold
standard’’ argument in these studies has been reversal of a
phenotype when a miRNA deficiency is combined with a target
deficiency or knockdown and when target overexpression leads
to a roughly similar phenotype. However, constitutive downregu-
lation or absence of the target and its overexpression can exert
multiple effects beyond those resulting from dynamic miRNA-
mediated regulation of the target transcript in a physiological
context. Thus, given the complexity of miRNA-mediated regula-
tion of gene expression, it has been difficult to explore the biolog-
ical significance of a single miRNA-mRNA interaction in vivo.
We sought to address this question by mutating the binding
site for a given miRNA in the 30 UTR of its target and studying
cells of the immune system with their aforementioned highly dy-
namic features. We reasoned that a desired experimental model
to address this question should satisfy the following require-
ments for a chosen miRNA-target mRNA pair: (1) both should
be expressed in multiple immune cell types and have pro-
nounced effects on their function supported by genetic evi-
dence; (2) expression of both should be modulated in the course
of the immune response; and (3) the mRNA 30 UTR should have a
single miRNA seed target sequence whose mutation annuls
regulation. miR-155, whose expression is induced upon activa-
tion of multiple types of immune cells, with diverse functions un-
der physiologic conditions as well as in the course of the immune
response, is an ideal candidate to serve this purpose (Vigorito
et al., 2013). Consistent with its pleiotropic effects, miR-155 was
shown to recruit Ago complexes to 200 seeds or 1.5% of all
miRNA bound sites in the transcriptome of activated T cells
(Loeb et al., 2012). Previous analysis of mutations of the miR-
155 target seed sequence in Aicda (AID) and Spi1 (PU.1) demon-
strated that a single target can account for a specific miR-155
function in B cells (Dorsett et al., 2008; Lu et al., 2014; Teng
et al., 2008). Here, we chose to explore a role for miR-155-
dependent regulation of suppressor of cytokine signaling 1
(SOCS1), because it is expressed in multiple immune cell types
in an inducible manner and serves as a pivotal regulator of
many cytokine signaling pathways (Ilangumaran et al., 2004;
Yoshimura et al., 2007). Several studies including our own
implicated miR-155 regulation of SOCS1 in multiple complex
phenotypes controlled by miR-155. The miR-155-dependent
repression of SOCS1 appeared essential for competitive fitness
of Foxp3+ regulatory T (Treg) cells, for Th17 cell generation and
dendritic cell (DC) function during experimental autoimmune
encephalomyelitis (EAE) induction, and for CD8+ and NK cell
responses during viral infection (Dudda et al., 2013; Lu et al.,
2009; Murugaiyan et al., 2011; O’Connell et al., 2010; Zawislak
et al., 2013). The latter findings were contradicted by a recent
study that was unable to identify a role for miR-155-dependent
repression of SOCS1 in CD8+ T cell responses to viral infection
(Gracias et al., 2013). These results illustrate the aforementioned
difficulties in mechanistic understanding of miRNA biological
function.
To investigate the biological significance of a single miRNA-
mRNA interaction in vivo, we generated mice with mutations
specifically disrupting the interaction between miR-155 and
SOCS1 and selectively abolishing its regulation by miR-155.
With these mice, we found that some biological phenotypes
associated with the function of miR-155 can indeed be attributed
to the regulation of SOCS1, whereas this same interaction can
be dispensable in different cellular and biological contexts. Our
data suggest that the relevance of a single miRNA-mRNA inter-
action is dependent on context and cell type and highlight the
complexity of miRNA regulatory networks.
RESULTS
Genetic Disruption of the miR-155-Mediated
Repression of SOCS1 in Mice
Our previous studies suggested that miR-155-mediated repres-
sion of SOCS1 confers Treg cell competitive fitness (Lu et al.,
2009). This conclusion was supported by the observation of a
comparable reduction in Treg cell numbers upon deletion of
miR-155 or overexpression of SOCS1 (Lu et al., 2009). The trans-
genic overexpression of SOCS1 in T cells precludes, however,
stringent mechanistic analysis of the contribution of miR-155-
mediated SOCS1 regulation to controlling Treg cell homeostasis
and other phenotypes associated with miR-155 deficiency (An-
droulidaki et al., 2009; Lu et al., 2009; O’Connell et al., 2010).
This approach also does not rule out the possibility that a
broader spectrum of miR-155 targets besides SOCS1 could be
involved in the observed effects. To directly test the impact of
SOCS1 regulation by miR-155, and to explore to what extent
the regulation of a single target alone can account for miRNA
function, we generated mice harboring mutations in the putativemiR-155 target site in the 30 UTR of SOCS1 (SOCS1KI) (Fig-
ure S1). SOCS1 protein amounts were increased in T cells iso-
lated from SOCS1KI mice when compared to their wild-type
(WT) littermate controls to a degree similar to that observed in
miR-155-deficient T cells (Figures 1A and 1B). This result sug-
gested that the mutations introduced in the miR-155 target site
in the 30 UTR of SOCS1 resulted in the ablation of miR-155-
dependent SOCS1 repression in SOCS1KI mice. Moreover,
retroviral overexpression of miR-155 was able to reduce the
elevated SOCS1 protein levels in miR-155-deficient, but not in
SOCS1KI, T cells (Figure 1C). In contrast, overexpression of
miR-150, used as a control in this experiment, was able to simi-
larly reduce amounts of its target Myb in both miR-155-deficient
and SOCS1KI T cells (Xiao et al., 2007). Finally, the de-repression
of SOCS1 resulting from introduced 30 UTR mutations was miR-
155 specific as shown by the fact that overexpression of miR-19,
another miRNA capable of targeting SOCS1 (Pichiorri et al.,
2008; Simpson et al., 2014), in SOCS1KI or miR-155-deficient
or -sufficient T cells resulted in comparable reductions in the
SOCS1 protein expression (Figure S2). As a consequence, in
Treg cells isolated from SOCS1KI mice, we were able to observe
reduced activation of Stat5, whose phosphorylation is negatively
regulated by SOCS1, consistent with our previous finding of
increased amounts of SOCS1 and attenuated IL-2 signaling
in miR-155-deficient Treg cells (Figure 1D; Lu et al., 2009).
Together, these results demonstrate that miR-155-dependent
regulation of SOCS1 is abolished in SOCS1KI mice.
miR-155-Mediated SOCS1 Regulation Confers Treg Cell
Competitive Fitness
In contrast to reduced Treg cell numbers in miR-155-deficient
mice, the Treg cell population was not diminished in size in
SOCS1KI mice in comparison to WT littermates, despite in-
creased SOCS1 protein amounts and reduced Stat5 activation
in SOCS1KI Treg cells (Figure 2). Therefore, de-repression of
additional miR-155 targets in Treg cells or other cell types might
directly or indirectly account for the aforementioned Treg cell
deficiency in miR-155KO mice. Accordingly, the diminished
Treg cell population was not fully restored upon SOCS1 ablation
in Treg cells in miR-155KO mice (Figure S3), although the Treg
cell-restricted SOCS1 deficiency did increase Treg cell numbers
in miR-155-sufficient mice in agreement with our previous report
(Lu et al., 2009).
In order to examine the Treg-cell-autonomous role of
miR-155-mediated SOCS1 repression in controlling Treg cell
numbers, we transferred WT bone marrow (BM) precursor cells
from WT mice mixed with BM cells from SOCS1KI or miR-
155KOmice at a 1:1 ratio into irradiated T-cell-deficient recipients
as described previously (Lu et al., 2009). Four months after BM
transfer, we observed a comparable 30%–50% reduction in
the frequencies of SOCS1KI and miR-155KO Treg cells within
the thymic and peripheral CD4+ T cell subsets as compared
to the corresponding WT cell subsets in the control mixed chi-
meras (Figures 3A and 3B). Thus, these experiments suggested
a non-redundant cell-intrinsic role for miR-155-mediated SOCS1
repression in conferring competitive fitness to Treg cells (Lu
et al., 2009). Moreover, we also detected substantial decreases
in the splenic SOCS1KI CD4+ and CD8+ T cell subsets similar
to those in miR-155KO compartments in comparison to theirImmunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc. 53
Figure 1. De-repression of SOCS1 in Mice
Harboring Mutations in the miR-155 Target
Site in the 30 UTR of Socs1
(A and B) Immunoblot analysis of SOCS1 amounts
in different immune cell subsets isolated frommiR-
155KO and SOCS1KI mice (n = 3–5). Results are
expressed as means ± SD.
(C) Retroviral miR-155 or control miR-150 vectors
equipped with a GFP reporter were expressed in
T cells from miR-155KO and SOCS1KI mice. GFP+
cells were sorted 4 days after retroviral trans-
duction and the amounts of SOCS1 and Myb
proteins were assessed.
(D) Immunoblot analysis of total and phospho-
Stat5 (pStat5) in SOCS1KI Treg and Tconv cells.
Densitometric expression values of SOCS1, Myb,
total Stat5, or pStat5 normalized based on b-actin
expression values and fold changes are shown
below the corresponding lanes.
The data are representative of two independent
experiments (n = 2–4). See also Figures S1 and S2.wild-type counterparts (Figure 3C). These results provided an
experimental proof for the previously suggested role for miR-
155-dependent SOCS1 repression in the regulation of peripheral
effector T (Teff) cell numbers in competitive settings (Lu et al.,
2009).
Intermediate EAE Severity in SOCS1KI in Comparison to
WT and miR-155KO Mice
Previously, two studies demonstrated a role for miR-155 in
driving inflammatory responses during EAE (Murugaiyan et al.,
2011; O’Connell et al., 2010). Impaired Th1 and Th17 cell re-
sponses as well as defective pro-inflammatory cytokine produc-
tion by DCs were suggested to result in the reduced EAE
observed in miR-155-deficient mice. Although miR-155 could
promote EAE through modulation of multiple targets and path-
ways, SOCS1 repression by miR-155 was proposed in both
studies as a potential molecular mechanism behind the afore-
mentioned phenomena due to a well-established role of
SOCS1 in regulating autoimmune responses (Alexander et al.,
1999; Evel-Kabler et al., 2006; Hanada et al., 2003; Kinjyo
et al., 2002; Marine et al., 1999). However, direct genetic evi-
dence supporting the role of miR-155-mediated SOCS1 repres-
sion in EAE was lacking. To directly address this issue, we first
induced EAE in SOCS1KI mice to investigate how loss of miR-
155-mediated SOCS1 repression could impact autoimmune dis-54 Immunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc.ease progression. As shown in Figure 4A,
mice with miR-155 deficiency exhibited
an attenuated disease phenotype upon
EAE induction, in agreement with previ-
ous studies (Murugaiyan et al., 2011;
O’Connell et al., 2010). On the other
hand, we observed an intermediate dis-
ease phenotype in SOCS1KI mice as
compared to the severe or attenuated
disease observed in WT littermates or
miR-155KOmice, respectively (Figure 4A).
A markedly reduced disease severity
could already be detected in SOCS1KImice on day 17 of EAE induction compared toWT controls where
the differences between SOCS1KI and miR-155KO mice were
insignificant (Figure 4A). Consistent with this finding, frequencies
of IFN-g+ and IL-17+ CD4+ Teff cells in the brain of SOCS1KI mice
were lower than those observed in WT control mice, but higher
than in miR-155KO mice (Figure 4B). The intermediate EAE dis-
ease phenotype as well as IFN-g and IL-17 responses in
SOCS1KI mice harboring miR-155-resistant SOCS1 alleles
were in line with the notion that a complex phenotype conferred
by a given miRNA can depend on multiple targets of this miRNA.
Because both SOCS1 and miR-155 regulate immune re-
sponses in both T cells and non-T cell populations, it was
possible that miR-155-mediated SOCS1 repression in T cells
as well as other immune cell types could impact the outcome
of autoimmune and inflammatory diseases (Murugaiyan et al.,
2011; O’Connell et al., 2010). Indeed, it was suggested that
miR-155 could promote the generation of inflammatory T cells
and associated autoimmunity through modulating the produc-
tion of pro-inflammatory cytokines by DCs via targeting
SOCS1 (Murugaiyan et al., 2011; O’Connell et al., 2010). How-
ever, unlike DCs isolated from miR-155KO mice, SOCS1KI and
WT DCs produced similar amounts of pro-inflammatory cyto-
kines upon LPS stimulation (Figure S4 and data not shown). To
examine the T-cell-intrinsic role of miR-155-mediated SOCS1
repression in EAE, we induced EAE in mixed BM chimeras as
Figure 2. SOCS1KI Mice Did Not Exhibit Reduced Treg Cell Numbers
(A and B) FACS analysis of (A) thymus and (B) spleen in 6- to 8-week-old SOCS1KI mice and wild-type littermates. Percentages of different thymocyte and
splenocyte subsets are shown.
(C–F) Cellularity of the thymus and spleen (C), absolute numbers of thymus and splenic total CD4+ T cells (D), and the proportion (E) as well as the absolute
numbers of thymus and splenic Foxp3+CD4+ T cells (F) in SOCS1KI and WT mice are shown. The data are shown as mean ± SD and are representative of four
independent experiments (n = 4–8).
See also Figure S3.previously described (Murugaiyan et al., 2011; O’Connell et al.,
2010). Despite a similar EAE severity among all three groups of
mixed BM chimeras (BM transplant composition: CD45.1+
WT + WT; CD45.1+ WT + SOCS1KI; CD45.1+ WT + miR-
155KO), the frequency of IL-17-producing CD4+ Teff cells within
miR-155-deficient CD45.2+CD4+ Teff cells in the brain was
severely reduced as compared to CD45.1+ miR-155-sufficient
counterparts, in agreement with previous studies (Figure 4C).
In contrast, we did not detect any difference in the frequency
of IL-17-producing CD4+ Teff cells within the SOCS1KI and WT
Teff cell subset in the brain. These results indicate that miR-
155-mediated SOCS1 repression is not required for the differen-
tiation of Th17 cells (Figure 4C). Consistent with this finding,
naive CD4+ T cells isolated from SOCS1KI and control mice ex-
hibited a comparable capacity to differentiate into Th17 cells
in vitro, whereas Th17 cell differentiation of miR-155-deficient
T cells was impaired, as previously reported (Figure S5; Muru-
gaiyan et al., 2011; O’Connell et al., 2010). Thus, it is likely thatthe diminished competitive fitness of Teff cells in the absence
of miR-155-mediated regulation of SOCS1 contributes to the
attenuated EAE progression and diminished Th17 cell numbers
in the brains of SOCS1KI mice (Figures 3C and 4A). Indeed,
further analysis showed a marked reduction of both SOCS1KI
and miR-155KO CD4+ Teff cells as compared to the correspond-
ingWTcontrol populations in themixedBMchimeras (Figure 4D).
Thus, the absolute numbers, but not the frequency, of encepha-
litogenic SOCS1KI CD4+ effector cells were reduced. In agree-
ment with this finding, MOG35-55 peptide-specific proliferative
in vitro response of splenic CD4+ T cells isolated from SOCS1KI
mice subjected to EAE induction was intermediate in magnitude
in comparison to those of WT and miR-155-deficient T cells
(Figure 4E). These results suggested that the ameliorated auto-
immune disease in miR-155-deficient mice could be in part
attributed to impaired Teff cell homeostasis resulting from
the lack of regulation of SOCS1 expression. However, the
latter did not noticeably contribute to the defective Th17 cellImmunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc. 55
Figure 3. miR-155-Mediated SOCS1 Regu-
lation Is Critical to Maintain Normal Treg
and Tconv Cell Numbers in a Competitive
Setting
(A) Ratios of frequencies of CD45.1Foxp3+ and
CD45.1+Foxp3+ Treg cells within each donor-
derived CD4+ T cell population from peripheral
blood lymphocytes 100 days after BM transfer.
(B) Treg cell frequencies within each donor-
derived T cell population fromboth the thymus and
spleen 120 days after BM transfer.
(C) Ratios of frequencies of thymic and splenic
CD45.1Foxp3+ and CD45.1+Foxp3+ Treg cells
within each donor-derived CD4+ T cell population
120 days after BM transfer.
(D and E) Ratios of frequencies of CD45.1Foxp3
and CD45.1+Foxp3 (D) CD4+ and (E) CD8+ Tconv
cells within each donor-derived compartment
from peripheral blood lymphocytes 100 days after
BM transfer.
Each symbol represents an individual mouse, and
the data are shown as mean ± SD.differentiation and the altered cytokine production by DCs asso-
ciated with miR-155 deficiency.
SOCS1 Regulation by miR-155 Is Dispensable for T Cell
Responses to LCMV Infection
Recent studies have demonstrated a severe defect in antiviral re-
sponses of miR-155-deficient T cells. To test whether miR-155-
dependent modulation of SOCS1 played an important role in
antiviral T cell responses, three groups of mixed BM chimeras
described above were infected with LCMV Armstrong. On
day 7 of infection, we analyzed LCMV-specific T cell responses
and compared the proportion of responding cells derived from
either CD45.2+ WT, miR-155KO, or SOCS1KI BM to the corre-
sponding CD45.1+ marked WT control cells in each individual
mouse. We observed similar proliferative activity of SOCS1KI
and WT CD4+Foxp3 Teff cells (30% dividing cells based on
expression of Ki-67), whereas the proliferative potential of miR-
155-deficient Teff cells was severely reduced (Figure 5A).
Consistent with a SOCS1 regulation-independent role of miR-
155 in antiviral CD4+ Teff cell responses, SOCS1KI and WT
T cells showed a comparable frequency of activated CD44+
CD62L (Figure 5B) and IFN-g-producing LCMV-GP61-specific
CD4+ T cells (Figure 5C). In contrast, the numbers of activated
and LCMV-GP61-specific miR-155
KO CD4+ T cells were greatly
reduced as compared to the correspondingWT controls (Figures
5A–5C). SOCS1KI andWT control Treg cells expanded to a com-56 Immunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc.parable degree whereas only very few
Treg cells were detectable among miR-
155-deficient CD4+ T cells (data not
shown). CD8+ T cells specific for LCMV-
GP33 or LCMV-NP396 peptideswere iden-
tified by MHC class I tetramer staining
and peptide-specific IFN-g production.
Similar to antiviral CD4+ T cells, the re-
sponses of SOCS1KI and WT control
CD8+ T cells were comparable, whereas
miR-155KO CD8+ T cells exhibited asevere defect in response to LCMV (Figures 5D and 5E). The
observation that the induction of miR-155 in CD8+ T cells de-
pends on TCR signal strength raised the possibility that the
requirement of miR-155-dependent repression of SOCS1 might
depend on TCR affinity and that low-affinity, but not high-affinity,
SOCS1KI CD8+ T cells might be able to respond to viral infection
(Dudda et al., 2013). To exclude this possibility, we generated
WT, SOCS1KI, and miR-155KO P14 TCR transgenic (tg) mice.
Naive CD8+ T cells expressing LCMV-GP33-specific TCR were
isolated from either miR-155KO or SOCS1KI CD45.2+ P14 TCR
tg mice and co-transferred with allelically marked CD45.1+
CD45.2+ WT P14 TCR T cells into CD45.1+ hosts that were sub-
sequently infected with LCMV Armstrong. Both SOCS1KI and
WT control P14 T cells showed robust expansion by day 7 of
infection, whereas miR-155KO cells were strongly outnumbered
by their WT control population (Figure 5F). Thus, the response
of both CD4+ and CD8+ T cells to acute viral infection was inde-
pendent of miR-155-dependent regulation of SOCS1.
Cell-Type-Dependent Role of miR-155-Dependent
Regulation of SOCS1 during MCMV Infection
Besides CD8+ and CD4+ T cells, NK cells play a major role in
antiviral immunity. To explore a role for SOCS1 regulation by
miR-155 in NK versus CD8+ T cell responses to the same viral
pathogen, we used mouse cytomegalovirus (MCMV) infection
in SOCS1KI, miR-155KO, and WT mice. In addition, these
Figure 4. Intermediate EAE Disease Phenotype in SOCS1KI Mice Compared to WT and miR-155KO Mice
(A) EAE was induced in SOCS1KI, miR-155KO, and WT control mice. Their disease severity was scored regularly based upon clinical symptoms. The data are
shown as mean clinical scores ± SD and are pooled from two independent experiments (n = 10).
(B) Frequency of IL-17+ and IFN-g+ T cells in spleen and brain from WT, SOCS1KI, and miR-155KO mice induced with EAE.
(C) Ratios of frequencies of CD45.1IL-17+ and CD45.1+IL-17+ cells within each donor-derived CD4+ T cell population in the brain.
(D) Ratios of frequencies of CD45.1Foxp3CD4+ and CD45.1+Foxp3CD4+ Teff cells within each donor-derived compartment in the brain. Each symbol
represents an individual mouse, and the data are shown as mean ± SD.
(E) In vitro proliferative responses of WT, SOCS1KI, and miR-155KO splenic CD4+ T cells after restimulation with indicated concentrations of MOG35–55 peptide.
T cells were isolated on day 25 after EAE induction and cultured for 72 hr. Their proliferation wasmeasured by 3[H]thymidine incorporation. The data are shown as
mean cpm ± SD and are representative of 4 independent experiments (n = 8–12).
See also Figures S4 and S5.experiments allowed us to assess CD8+ T cell responses in a
model of acute viral infection different from LCMV. MCMV en-
codes the m157 glycoprotein that serves as a cognate ligand
for activating NK cell receptor Ly49H (Arase et al., 2002) and
numerous CD8+ T cell epitopes with distinct response kinetics
(Snyder et al., 2008). First, we assessed antiviral responses of
SOCS1KI CD8+ T cells by infecting mixed bone-marrow chi-
meras with MCMV and analyzing antigen-specific responses
using MCMV-M45 tetramers. Similar to acute LCMV infection,
we found that antigen-specific WT and SOCS1KI CD8+ T cells
were generated with a comparable efficiency, whereas the
numbers of antigen-specific miR-155KO CD8+ T cells were
strongly reduced (Figure 6A). Next, we analyzed the virus-spe-
cific expansion of Ly49H+ NK cells, which we have previously
found to be strongly dependent on miR-155 (Zawislak et al.,
2013). miR-155KO NK cells have increased SOCS1mRNA during
MCMV infection. However, our previous study implied that addi-
tional miR-155 targets besides SOCS1 could account for the
defect of antiviral NK cells. In addition, miR-155 has been pro-posed to regulate NK cell functions by modulating the expres-
sion of multiple signaling molecules including SHIP1 (Sullivan
et al., 2013; Trotta et al., 2013). To test whether the miR-155-
mediated regulation of SOCS1 alone impacts the expansion of
antiviral NK cells, splenic NK cells from WT, SOCS-1KI, or miR-
155KO were co-transferred with congenically distinct marked
WT control NK cells into mice deficient for Ly49H. After MCMV
infection, expansion of adoptively transferred Ly49H+ NK cells
was analyzed on day 7 after infection. SOCS1KI and miR-
155KO NK cells were outnumbered by5- to 10-fold by WT con-
trol cells present within the same mouse (Figure 6B). Thus, the
inability of miR-155 to regulate SOCS1 in the SOCS1KI NK cells
closely resembled the defect of complete absence of miR-155 in
NK cells during MCMV infection. This surprising result revealed
that the SOCS1 regulation by miR-155 is crucial for the expan-
sion of virus-specific NK cells, but not CD8+ T cells, during
MCMV infection. On the other hand, we failed to observe signif-
icant effect of not only deficiency in SOCS1 regulation by miR-
155, but also miR-155 itself on the numbers and responses toImmunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc. 57
Figure 5. SOCS1 Regulation by miR-155 Is Dispensable for Acute Antiviral T Cell Responses
Mixed BM chimeras were infected with LCMV Armstrong and splenic T cells were analyzed by flow cytometry on day 7 of infection.
(A) Expression of Ki67 in Foxp3CD4+ Teff cells. Depicted are representative FACS plots and ratios of the proportions of Ki67+ cells among CD45.2+CD4+ WT,
SOCS1KI, or miR-155KO cells versus CD45.1+CD4+ WT controls.
(B) Percentage of activated CD44+CD62LFoxp3CD4+ Teff cells.
(C) Ratios of IFN-g-producing CD4+ Teff cells upon stimulation with LCMV-GP61 peptide.
(D and E) Percentage and ratios of LCMV-GP33 and -NP396 specific tetramer binding (D) and IFN-g production of splenic CD8+ T cells (E).
(F) CD45.2+ miR-155KO or SOCS1KI and CD45.1+CD45.2+ naive CD8+ P14 TCR-tg T cells (104 each) were co-transferred into CD45.1+ WT hosts prior to infection
with LCMV Armstrong. Splenic T cells were analyzed on day 8 pi.
The data are shown as mean ± SD and are pooled from two independent experiments (n = 7).
58 Immunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc.
Figure 6. Cell-Type-Specific Role of miR-155-Mediated Regulation of SOCS1 during Acute Viral Infection
(A) Mixed BM chimeras were infected with MCMV and percentage and ratios of MCMV-M45-specific tetramer binding of splenic CD8+ T cells were analyzed on
day 7 pi.
(B) CD45.2+miR-155KO or SOCS1KI andCD45.1+WTNK cells (23 105 each) were co-transferred into Ly49H-deficient hosts prior to infectionwithMCMV. Ratios of
transferredLy49H+NKcellswere analyzed in thespleenonday7pi.Thedata areshownasmean±SDandare representativeof 3 independent experiments (n=3–5).
(C) CD45.1+ WT, SOCS1KI, or miR-155KO OT-I CD8+ T cells (1 3 104 each) or NK cells (2 3 105 each) were transferred into CD45.2+ WT B6 or Ly49H-deficient
hosts prior to infection with MCMV-OVA or MCMV, respectively. CD45.1+ OT-I CD8+ T cells and CD45.1+ Ly49H+ NK cells were FACS sorted on day 4 pi and
RNA-seq analysis was performed. Scatterplots depict log fold changes of gene expression in SOCS1KI (red) and miR-155KO (blue) or both genotypes (black).
(D) Bar graphs depict the percentage of genes similarly regulated in both SOCS1KI andmiR-155KO from all the genes that were significantly changed inmiR-155KO
in indicated cell types. Sequencing data represent analysis of three biological replicates.Nippostrongylus brasiliensis infection of type 2 innate lymphoid
cells expressing increased amounts of miR-155 in comparison
to other ILC subsets (data not shown and http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE37448).
In order to quantify the number of genes whose expression
was directly or indirectly regulated through the binding of miR-
155 to the SOCS1 30 UTR in these two different cell types, we
performed RNA-seq analysis of gene expression. To compare
virus-specific WT, miR-155KO, and SOCS1KI CD8+ and NK cells
in mice with an intact WT myeloid and non-myeloid compart-
ment, we performed adoptive transfers of WT, SOCS1KI, and
miR-155KO OVA-specific OT-I TCR transgenic CD8+ T cellssimilar to those used for NK cells (Figure 6B). Naive OT-1 CD8+
T cells were adoptively transferred into CD45.1+ WT mice and
then FACS sorted for mRNA preparation on day 4 after infection
with MCMV-OVA. Adoptively transferred SOCS1KI and WT OT-I
T cells showed comparable expansion on day 7 of infection
whereas the expansion of miR-155KO OT-I was strongly reduced
(data not shown) in full agreement with our analysis of polyclonal
antiviral CD8+ T cell responses (Figure 6A). For comparison of
virus-specific NK and CD8+ T cells, we adoptively transferred
WT, SOCS1KI, and miR-155KO NK cells as described above
and FACS-purified Ly49H+ cells for mRNA preparation on
day 4 of infection. We found that only a small fraction (<2%) ofImmunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc. 59
Figure 7. Context-Dependent Role of miR-155-SOCS1 Interaction for Antiviral CD8+ T Cells
(A and B) CD45.2+ miR-155KO or SOCS1KI and CD45.1+ P14 TCR-tg T cells (104 each) were co-transferred into CD45.1+CD45.2+ WT hosts prior to infection with
LCMV Armstrong (Arm) or clone 13.
(A) Ratios of P14 T cells in the spleen on day 8 pi.
(B) Kinetic analysis of P14 T cells in peripheral blood of LCMV clone 13-infected mice.
(C) Mixed BM chimeras were infected with MCMV and the percentage and ratios of MCMV-m38- and -m139-specific tetramer binding of splenic CD8
+ T cells was
analyzed on day 40 pi.
The data are shown as mean ± SD and are representative of two to three independent experiments (n = 4–7). See also Figures S6 and S7.the genes differentially regulated in miR-155KO versus WT CD8+
T cells were also dysregulated in SOCS1KI CD8+ T cells whereas
expression of the majority of genes was not significantly altered
(Figures 6C and 6D). These results suggest that the miR-155-
SOCS1 axis has rather minor effects for the global gene expres-
sion in antiviral CD8+ T cells. In contrast, a large fraction (>40%)
of the genes were similarly regulated in both miR-155KO and
SOCS1KI NK cells (Figures 6C and 6D), suggesting that miR-
155-mediated regulation of SOCS1 plays a major role in miR-
155-dependent regulated gene expression in antiviral responses
of NK cells. This cell-type-specific difference in the dependence
of global gene expression on the miR-155-SOCS1 axis trans-
lates into a strict requirement of SOCS1 regulation by miR-155
for the expansion of virus-specific NK cells, but not CD8+
T cells, during MCMV infection.
Context-Dependent Role of miR-155-SOCS1 Interaction
for Antiviral CD8+ T Cells
Our experiments showed a distinct requirement for a single
miRNA-target interaction for responses of adaptive and innate
cytotoxic lymphocytes to acute viral infection. Next, we wanted
to test a requirement for the regulation of SOCS1 by miR-155,
which was dispensable for CD8+ T cell responses to acute
LCMV infection, in the context of chronic infection. To address
this question, we transferred SOCS1KI and congenically marked
WT control P14 TCR tg CD8+ T cells into recipient mice that were
subsequently infected with LCMV Armstrong or clone 13 to
induce an acute and resolving or a chronically persisting viral
infection, respectively. In agreement with the experiments60 Immunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc.described above, both SOCS1KI and WT T cells showed similar
robust expansion on day 8 of LCMV Armstrong infection (Figures
5F and 7A). On day 8 of LCMV clone 13 infection, however,
SOCS1KI T cells were underrepresented when compared to
WT control cells and were gradually lost over the course of
persistent infection (Figures 7A and 7B). miR-155KO P14 T cells
exhibited a severe expansion defect during acute LCMV infec-
tion and were almost undetectable on day 8 of chronic LCMV
infection (Figure S6). Thus, the miR-155-mediated regulation of
SOCS1 expression was superfluous for the acute expansion of
CD8+ T cells, but was indispensable for the maintenance of the
antiviral T cell response during chronic infection.
Persistent LCMV clone 13 infection is characterized by contin-
uous viral replication and chronic T cell stimulation. In contrast,
MCMV persistence is achieved through latency without contin-
uous viremia. During latency, some viral genes are intermittently
transcribed and T cells specific for the respective gene products
are intermittently stimulated and undergo progressive expansion
and terminal differentiation, a process termed ‘‘memory infla-
tion’’ (Snyder et al., 2008). SOCS1KI T cells were able to respond
to latent viral infection and underwent normal memory inflation.
We detected comparable frequencies of SOCS1KI and WT con-
trol T cells specific for ‘‘inflationary’’ MCMV antigens m38 and
m139 (Figure 7C). Both SOCS1
KI and WT inflated T cells
underwent terminal effector differentiation characterized by a
KLRG-1hiCD127lo phenotype (Figure S7). In contrast, m38- and
m139-specific miR-155
KO T cells were barely detectable (Fig-
ure 7C). Therefore, the T cell response to acute and latently per-
sisting viral infection was independent of miR-155-dependent
regulation of SOCS1 but was indispensable for the antiviral T cell
response during chronic persistent infection.
Together, our analysis of regulation of SOCS1 by miR-155
revealed its distinct impact on numbers and function of T cell
subsets and NK cells in physiologic settings and in settings of
autoimmunity and viral infection. These studies provide the first
genetic evidence that a single miRNA-mRNA interaction can
account for complex biological phenotypes in a cell-type- and
biological-context-dependent manner.
DISCUSSION
miR-155 is one of themost prominentmiRNA operating in the im-
mune system. Many miR-155 targets were identified and their
regulation by miR-155 has been proposed to affect a wide range
of immunological processes (Dorsett et al., 2008; Dudda et al.,
2013; O’Connell et al., 2009; Rodriguez et al., 2007; Teng
et al., 2008; Vigorito et al., 2007; Zawislak et al., 2013). Conven-
tional genetic approaches such as the germ-line- or cell-type-
restricted ablation of individual miRNAs have been helpful in
identifying major phenotypes associated with miRNA function
but are unable to reveal the role of individual miRNA-mRNA inter-
actions. Although prior work relying on the overexpression,
knockdown, or complete ablation of specific miRNA targets
have provided correlative evidence for the biological role of their
regulation, conflicting data emerged from these studies. Direct
testing of the biological significance of individual miRNA-
mRNA interactions requires the genetic disruption of miRNA
binding to a specific target. Such approaches have previously
been used to explore the regulation of AID and PU.1 by miR-
155 in the B cell lineage (Dorsett et al., 2008; Lu et al., 2014;
Teng et al., 2008). However, these studies did not address a
role of a given miRNA-dependent regulation in different biolog-
ical and cellular settings. Through side-by-side comparison of
mice harboring the SOCS1 allele uncontrollable by miR-155
and mice lacking miR-155, we isolated the effect of a miRNA
on one of its targets and demonstrated the biological signifi-
cance of a single target repression in miRNA-mediated regula-
tion of the immune response during autoimmunity and infection.
Previous studies showed that the expression of miR-155 in
Treg cells is required to maintain normal Treg cell numbers
both in the thymus and periphery (Kohlhaas et al., 2009; Lu
et al., 2009). The Treg cell phenotype observed in miR-155KO
mice was at least in part attributed to attenuated IL-2 signaling
in the absence of miR-155-mediated regulation of SOCS1 (Lu
et al., 2009). Indeed, our experiments unequivocally demon-
strated the Treg-cell-intrinsic role of miR-155-mediated SOCS1
repression in conferring Treg cell competitive fitness. However,
in contrast to the reduced Treg cell subset observed in miR-
155KO mice, Treg cell numbers were unaffected in SOCS1KI
mice. These results indicate that, in contrast to the non-redun-
dant role of miR-155-mediated regulation of SOCS1 in
competitive settings, additional targets contribute to the miR-
155-dependent Treg cell maintenance in non-competitive set-
tings. This notion is also supported by the observation that
even a complete ablation of SOCS1 in Treg cells does not rescue
the diminished Treg cell population size in miR-155-deficient
mice. Moreover, the altered function of miR-155-deficient non-
Treg cell populations could also contribute to the impairedTreg cell development and maintenance in miR-155-deficient
mice. Finally, our observation of normal Treg cell numbers in
SOCS1KI mice despite reduced pStat5 activation suggests that
a somewhat relaxed demand for IL-2 signaling enabled normal
Treg cell numbers in a non-competitive setting. It has been
recently reported that a population of CD44hiCD62LloCCR7lo
Treg cells relies on ICOS signaling rather than IL-2 for their
maintenance in vivo (Smigiel et al., 2014). Thus, it is also possible
that the latter Treg cell subset is maintained at the expense of
Treg cells that are more sensitive to diminished IL-2 signaling
in SOCS1KI mice.
Several studies have demonstrated a pivotal role of miR-155 in
EAE through promoting pathogenic Th17 cell responses (Muru-
gaiyan et al., 2011; O’Connell et al., 2010; Zhang et al., 2014).
Reduced numbers of effector Th17 cells in miR-155-deficient
mice were shown to be largely due to the T-cell-intrinsic lack
of miR-155-mediated gene regulation. Additionally, impaired
production of pro-inflammatory cytokines by miR-155-deficient
DCs could also contribute to the attenuated EAE progression
in miR-155-deficient mice (Murugaiyan et al., 2011; O’Connell
et al., 2010). Although the exact molecular mechanisms ac-
counting for these phenotypes are currently unknown, the loss
of miR-155-mediated SOCS1 repression has been proposed to
be responsible for defective DC functions (Murugaiyan et al.,
2011; O’Connell et al., 2010). Moreover, miR-155-mediated
SOCS1 repression has also been shown to promote Th17 cell
differentiation through modulation of JAK-STAT pathway in a
T-cell-autonomous manner (Yao et al., 2012). However, we did
not observe any alteration in cytokine production by DCs nor
did we detect impaired Th17 cell responses of T cells upon the
selective abrogation of SOCS1 regulation by miR-155. These
results clearly suggested that SOCS1 repression by miR-155
is dispensable for the aforementioned biological responses.
Instead, we found that miR-155-mediated SOCS1 regulation
contributed to EAE pathogenesis, probably through maintaining
the size of effector T cell populations, particularly at the site of
autoimmune inflammation. Collectively, our results indicate
that de-repression of SOCS1 together with other miR-155 tar-
gets is required to render miR-155KO mice largely resistant
to EAE.
Recent studies have demonstrated a severe defect of miR-
155-deficient T cells in response to viral infection. The vigorous
upregulation of miR-155 observed upon T cell activation enables
the expansion and accumulation of virus-specific Teff cells in the
acute phase of infection. It was suggested that miR-155 moder-
ately affected transcripts of a number of target genes associated
with type I interferon signaling (Gracias et al., 2013). The cumu-
lative effect of the miR-155-mediated downregulation of these
targets was proposed to counteract the anti-proliferative effect
of type I interferons during infection. In contrast, another study
attributed the defect of antiviral responses of miR-155-deficient
T cells to increased SOCS1 mRNA levels and showed that the
overexpression of SOCS1 results in a phenocopy of miR-155
deficiency, i.e., inhibition of the expansion of LCMV-specific
T cells (Dudda et al., 2013). Our analysis of SOCS1KI mice indis-
putably showed that the responses of both CD8+ and CD4+
T cells to acute viral infection were independent of miR-155-
mediated regulation of SOCS1. During chronic persistent viral
infection, however, the maintenance of virus-specific CD8+Immunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc. 61
T cells required the modulation of SOCS1 levels by miR-155.
SOCS1KI T cells were progressively lost during the chronic phase
of infection. These results suggest that increased SOCS1 levels
are detrimental during continuous T cell stimulation by viral anti-
gen or the altered inflammatory environment generated upon
persisting viral infection. SOCS1KI T cells could respond to
both acute and latent viral infection and undergo memory infla-
tion during latent MCMV infection. Although we failed to detect
a role for themiR-155-mediated regulation of SOCS1 expression
in CD8+ T cell responses during acute viral infection, this mech-
anism proved to be critical for the expansion of virus-specific NK
cells in the context of the same infection. Moreover, the fact that
in infected miR-155KO or SOCS1KI mice a large proportion of
genes was similarly regulated in NK cells, but not CD8+ T cells,
supported our in vivo observations. In addition, these findings
raised an interesting question as to whether distinct cytokine
signaling strength is required for activating the downstream tran-
scriptional programs in CD8+ T cells andNK cells. Alternatively, it
is also possible that the miR-155-mediated SOCS1 regulation is
redundant in CD8+ T cells, but not in NK cells, due to the
presence of other CD8+ T-cell-specific miR-155 targets that
could play a compensatory role in regulating cytokine-driven re-
sponses. Although the mechanisms determining cell-type-spe-
cific regulation of miRNA/target interactions remain to be further
investigated at a biochemical level, our side-by-side comparison
of the impact of miR-155 deficiency and of the inability of miR-
155 to regulate SOCS1 on the response of the two major cyto-
toxic lymphocyte subsets revealed a context-dependent and
cell-type-specific role of a single miRNA-target RNA interaction
during acute and latent versus persistent chronic viral infection
and highlight the complex and dynamic character of these
interactions.
The SOCS1KI mouse model enabled us to directly test the role
of an individual miRNA/target interaction in different biological
and cellular contexts. Nevertheless, it was possible that the mu-
tation of the SOCS1 30 UTRmight also affect potential binding of
miRNAs other than miR-155, or the recruitment of RNA binding
proteins that are required for SOCS1 regulation by other
miRNAs. We found that in both SOCS1KI and miR-155KO CD4+
T cells, the mutated 30 UTR can still be regulated by another
SOCS1-targeting miRNA, miR-19, and we cannot completely
rule out this seemingly unlikely scenario. Another possibility is
that themodulation of one target site might potentially also affect
the abundance of a specific miRNA and thereby influence the
regulation of other competing miRNA targets indirectly. A recent
study demonstrated that modulation of miRNA target abun-
dance is unlikely to cause significant effects on gene expression
because target repression can be released only after many
competing target sites (R1.5 3 105 target sites per cell) were
introduced (Denzler et al., 2014). Our previous unbiased analysis
of miR-155 targets via HITS-CLIP showed that any one of the
most abundant miR-155 targets is bound by less than
5%–10% of total miR-155 pool (Loeb et al., 2012). Thus, the
extent of regulation of other miR-155 targets cannot be per-
turbed in a meaningful way by excluding regulation of any single
miR-155 target (data not shown). Moreover, considering the
relatively low expression level of SOCS1 mRNA with only one
miR-155 binding site compared to the level of miR-155, one of
the highly expressed miRNAs in activated lymphocytes (Bosson62 Immunity 43, 52–64, July 21, 2015 ª2015 Elsevier Inc.et al., 2014), we do not anticipate that such effects significantly
contributed to the phenotypes observed in our study. Finally,
because complex miRNA-dependent cellular phenotypes might
require the coordinate repression of multiple target genes by a
givenmiRNA, our finding that miR-155-mediated SOCS1 regula-
tion plays an indispensable role in specific cellular and biological
contexts does not exclude the possible functional involvement of
other miR-155 targets.
In summary, our findings highlight that for related biological
functions, a given miRNA-target mRNA interaction can be
critical because de-repression of an individual target can
abolish miRNA-dependent phenotypes. In other cases, such
an interaction can have only a partial role or might even be
fully dispensable depending on the cellular and physiological
context.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are available in the Supplemental
Information.
Animals
The targeting construct harboring mutations in the miR-155 target site in the 30
UTR of SOCS1 was generated via recombineering (http://redrecombineering.
ncifcrf.gov/) on a B6 genetic background. miR-155KO and C57BL/6J mice
were purchased from the Jackson Laboratories. SOCS1fl and Klra8KO
mice were kindly provided by A. Yoshimura and S. Vidal, respectively. All
mice were used in accordance with guidelines from the Institutional Animal
Care Committee of the Memorial Sloan-Kettering Cancer Center.
Retroviral Transduction and Immunoblot Analyses
To overexpress miR-155 and control miR-150 in T cells, CD4+CD25CD62Lhi
naive T cells isolated from indicated mice were first activated by plate-bound
CD3 and CD28 antibodies (2 mg/ml each) and IL-2 (50 U) for 1 day and retro-
virally transduced with miR-155-expressing or control miR-150-expressing
pMDH-PGK-EGFP plasmids (Lu et al., 2009). Four days after initial retroviral
transduction, cells were harvested and sorted for GFP expression. FACS-
sorted GFP+ miR-155 (or miR-150 or miR-19a/b) -overexpressing cells as
well as different T cell subsets from indicated mice were lysed and subjected
to immunoblot analysis as described previously (Lu et al., 2009). SOCS1, Myb,
Stat5, phospho-Stat5, and b-actin (loading control) were visualized with
monoclonal antibodies ab62584 (Abcam), #1-1 (Upstate), #9363, #9359
(both from Cell Signaling Technology), and AC-74 (Sigma), correspondingly.
Protein quantitation was performed with NIH Image J software (http://rsb.
info.nih.gov/ij/).
Generation of Mixed Bone-Marrow Chimeras
TCRbdKO were irradiated (950 cGy) and rested overnight. The next day, bone
marrow cells were isolated from femurs and tibias of CD45.2+ WT, miR-155KO,
or SOCS1KI mice and CD45.1+ WT mice and depleted of CD90+ and NK1.1+
cells (Dynabeads Flow Comp). A 1:1 mixture of mutant or CD45.2+ WT control
and CD45.1+ WT cell populations (2.53 106 each) were i.v. injected into recip-
ients. Mice were kept on neomycin water for 3 weeks.
EAE
Mice were immunized s.c. with 100 mg MOG35-55 emulsified with complete
Freund’s adjuvant plus 200 ng pertussis toxin in 500 ml PBS. Animals were
scored three times a week for disease symptoms as described previously
(O’Connell et al., 2010).
Virus Infections
Mice were infected with cell culture-grown LCMV Armstrong (2 3 105 pfu i.p.)
or LCMV clone 13 (2 3 106 pfu i.v.). Salivary gland preparations of MCMV
(1 3 104 PFU) were injected i.p. as described previously (Zawislak et al.,
2013).
Adoptive Cell Transfer
NK cells were negatively enriched by NK cell isolation Kit (Miltenyi) (Sun et al.,
2009). TCR-tg T cells were stained with surface antibodies and then CD8+
CD44 naive cells were sorted on a FACS AriaII cell sorter (BD Biosciences).
Cells were washed and 104 TCR-tg T cells or 23 105 NK cells were transferred
by i.v. injection 4–12 hr prior to infection.
Quantification of Antigen-Specific T Cell Responses
Splenocytes were stained with multimers for LCMV-GP33, LCMV-NP396,
MCMV-M45, -m38, and -m139 or OVA257 produced from biotinylated mono-
mers provided by the NIH Tetramer facility. For cytokine production,
splenocytes were briefly incubated with indicated peptides and Brefeldin A
(Sigma-Aldrich) and then stained for intracellular cytokine production. For
live/dead discrimination, propidium iodide or LIVE/DEAD fixable yellow dye
(Molecular Probes) was used. Cells were analyzed on a LSRII cytometer (BD
Biosciences) and analyzed with FlowJo software (Treestar).
Gene Expression Profiling Analysis
For gene expression profiling analysis, CD45.2+ miR-155KO or SOCS1KI or
WT OT-I TCR-tg CD8+ T cells or NK cells were adoptively transferred into
CD45.1+ WT or Ly49H-deficient hosts, respectively, prior to infection with
MCMV-OVA or MCMV. OT-I CD8+ T cells or Ly49H+ NK cells were FACS
sorted on day 4 after infection and poly(A) RNA sequencing was performed
with three biological replicates for each cell type analyzed with an Illumina
HiSeq2500 platform.
Statistical Analysis
All statistical analyses were performed with GraphPad Prism5 software. Re-
sults are expressed as means ± SD. Differences between individual groups
were analyzed for statistical significance via the one-way ANOVA: *p < 0.05,
**p < 0.01, ***p < 0.001, ns = not significant.
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